• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱抑素M在乳腺癌中频繁发生表观遗传失活。

Frequent epigenetic inactivation of cystatin M in breast carcinoma.

作者信息

Schagdarsurengin U, Pfeifer G P, Dammann R

机构信息

AWG Tumour Genetics of the Medical Faculty, Institute for Human Genetics, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.

出版信息

Oncogene. 2007 May 10;26(21):3089-94. doi: 10.1038/sj.onc.1210107. Epub 2006 Nov 13.

DOI:10.1038/sj.onc.1210107
PMID:17099723
Abstract

Cystatin M is a potent endogenous inhibitor of lysosomal cysteine proteases. In breast carcinoma, cystatin M expression is frequently downregulated. It has been shown that cystatin M expression suppressed growth and migration of breast cancer cells. We examined the methylation status of the CpG island promoter of cystatin M in four breast cancer cell lines (MDAMB231, ZR75-1, MCF7 and T47D), in 40 primary breast carcinoma and in corresponding normal tissue probes by combined bisulphite restriction analysis. To investigate the effects of cystatin M expression on the growth of breast carcinoma, cystatin M was transfected in T47D. The cystatin M promoter was highly methylated in all four-breast cancer cell lines. Primary breast tumours were significantly more frequently methylated compared to normal tissue samples (60 vs 25%; P=0.006 Fisher's exact test). Treatment of breast cancer cells with 5-aza-2'-deoxycytidine (5-Aza-CdR), reactivated the transcription of cystatin M. Transfection of breast carcinoma cells with cystatin M caused a 30% decrease in colony formation compared to control transfection (P=0.002). Our results show that cystatin M is frequently epigenetically inactivated during breast carcinogenesis and cystatin M expression suppresses the growth of breast carcinoma. These data suggest that cystatin M may encode a novel epigenetically inactivated candidate tumour suppressor gene.

摘要

胱抑素M是溶酶体半胱氨酸蛋白酶的一种强效内源性抑制剂。在乳腺癌中,胱抑素M的表达经常下调。已有研究表明,胱抑素M的表达可抑制乳腺癌细胞的生长和迁移。我们通过联合亚硫酸氢盐限制分析,检测了四种乳腺癌细胞系(MDAMB231、ZR75-1、MCF7和T47D)、40例原发性乳腺癌以及相应正常组织样本中胱抑素M的CpG岛启动子的甲基化状态。为了研究胱抑素M表达对乳腺癌生长的影响,将胱抑素M转染至T47D细胞中。在所有四种乳腺癌细胞系中,胱抑素M启动子均高度甲基化。与正常组织样本相比,原发性乳腺肿瘤的甲基化频率显著更高(60%对25%;P=0.006,Fisher精确检验)。用5-氮杂-2'-脱氧胞苷(5-Aza-CdR)处理乳腺癌细胞,可重新激活胱抑素M的转录。与对照转染相比,用胱抑素M转染乳腺癌细胞导致集落形成减少30%(P=0.002)。我们的结果表明,在乳腺癌发生过程中,胱抑素M经常发生表观遗传失活,且胱抑素M的表达可抑制乳腺癌的生长。这些数据表明,胱抑素M可能编码一种新型的表观遗传失活候选肿瘤抑制基因。

相似文献

1
Frequent epigenetic inactivation of cystatin M in breast carcinoma.胱抑素M在乳腺癌中频繁发生表观遗传失活。
Oncogene. 2007 May 10;26(21):3089-94. doi: 10.1038/sj.onc.1210107. Epub 2006 Nov 13.
2
Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.在乳腺癌进展过程中,肿瘤抑制因子胱抑素M会发生表观遗传沉默。
Cancer Res. 2006 Aug 15;66(16):7899-909. doi: 10.1158/0008-5472.CAN-06-0576.
3
Cystatin m: a novel candidate tumor suppressor gene for breast cancer.胱抑素m:一种新的乳腺癌候选肿瘤抑制基因。
Cancer Res. 2004 Oct 1;64(19):6957-64. doi: 10.1158/0008-5472.CAN-04-0819.
4
Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.胱抑素M抑制人MDA-MB-435S细胞的恶性表型。
Oncogene. 2004 Mar 18;23(12):2206-15. doi: 10.1038/sj.onc.1207340.
5
Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.半胱氨酸蛋白酶抑制剂 M 在胃癌中表达降低,并与启动子超甲基化有关。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):1070-4. doi: 10.1016/j.bbrc.2009.12.022. Epub 2009 Dec 10.
6
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.Wnt信号通路在人类乳腺癌中的作用:假定的Wnt抑制剂Dickkopf-3(DKK3)在乳腺肿瘤中常常因启动子高甲基化而表达受抑。
Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.
7
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.SFRP2基因的启动子高甲基化是人类乳腺癌中一种高频改变和肿瘤特异性表观遗传标志物。
Mol Cancer. 2008 Nov 6;7:83. doi: 10.1186/1476-4598-7-83.
8
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer.位于1p31的CLCA2肿瘤抑制基因在乳腺癌中受到表观遗传调控。
Oncogene. 2004 Feb 19;23(7):1474-80. doi: 10.1038/sj.onc.1207249.
9
Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.人类肾细胞癌中候选抑癌基因HOXB13的表观遗传失活
Oncogene. 2006 Mar 16;25(12):1733-42. doi: 10.1038/sj.onc.1209200.
10
CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.CMTM5具有肿瘤抑制活性,且在癌细胞系中常因甲基化而沉默。
Clin Cancer Res. 2007 Oct 1;13(19):5756-62. doi: 10.1158/1078-0432.CCR-06-3082.

引用本文的文献

1
A Pan-Cancer Analysis of Cystatin E/M Reveals Its Dual Functional Effects and Positive Regulation of Epithelial Cell in Human Tumors.胱抑素E/M的泛癌分析揭示了其在人类肿瘤中的双重功能效应及对上皮细胞的正向调控作用。
Front Genet. 2021 Sep 17;12:733211. doi: 10.3389/fgene.2021.733211. eCollection 2021.
2
Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions.胱抑素M/E(胱抑素6):一种具有肿瘤抑制和肿瘤促进双重功能的双面半胱氨酸蛋白酶抑制剂。
Cancers (Basel). 2021 Apr 14;13(8):1877. doi: 10.3390/cancers13081877.
3
Identification of lncRNA-associated differential subnetworks in oesophageal squamous cell carcinoma by differential co-expression analysis.
通过差异共表达分析鉴定食管鳞状细胞癌中的 lncRNA 相关差异子网络。
J Cell Mol Med. 2020 Apr;24(8):4804-4818. doi: 10.1111/jcmm.15159. Epub 2020 Mar 12.
4
RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice.RASSF10 在肾癌中经常被表观遗传失活,其敲除会促进癌症易感小鼠的肿瘤形成。
Oncogene. 2020 Apr;39(15):3114-3127. doi: 10.1038/s41388-020-1195-6. Epub 2020 Feb 11.
5
Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.胱抑素E/M的低水平内化影响legumain活性和黑色素瘤细胞的迁移。
J Biol Chem. 2017 Sep 1;292(35):14413-14424. doi: 10.1074/jbc.M117.776138. Epub 2017 Jun 19.
6
In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.计算机模拟分析验证了福尔马林固定石蜡包埋的皮肤鳞状细胞癌组织的蛋白质组学研究结果。
Cancer Genomics Proteomics. 2016;13(6):453-465. doi: 10.21873/cgp.20008.
7
p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.p53直接激活胱抑素D/CST5以介导间充质-上皮转化:这可能是维生素D3发挥肿瘤抑制作用的一个环节。
Oncotarget. 2015 Jun 30;6(18):15842-56. doi: 10.18632/oncotarget.4683.
8
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth.ABCB4在人类癌症中经常发生表观遗传沉默,并抑制肿瘤生长。
Sci Rep. 2014 Nov 4;4:6899. doi: 10.1038/srep06899.
9
The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.凋亡相关酪氨酸激酶基因在人类癌症中经常发生高甲基化,并受表观遗传机制调控。
Genes Cancer. 2014 Sep;5(9-10):365-74. doi: 10.18632/genesandcancer.28.
10
Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.胱抑素SN的过表达对手术切除的食管鳞状细胞癌患者的生存有积极影响。
BMC Surg. 2013 May 28;13:15. doi: 10.1186/1471-2482-13-15.